Kamrul-Hasan Egyptian Liver Journal .2025;[Epub] CrossRef Impact of a high dietary fiber cereal meal intervention on the progression of liver fibrosis in T2DM with MASLD Xi-Shuang Chen, Hui-Zhen Liu, Fang Huang, Jian Meng, Jing-Xian Fang, Yu Han, Hui-Ming Zou, Qing Gu, Xue Hu, Qian-Wen Ma, Yue-Xia Han, Sui-Jun Wang Frontiers in Endocrinology .2025;[Epub] CrossRef Association between fibrosis-4 index and coronary heart disease: a population-based study Pan Jia, Mamajan Annamyradova, Genhao Fan, Qizhen Zhang, Yankun Song, Qiaozhi Li, Minghao Liu, Zuoying Xing, Yongxia Wang BMC Cardiovascular Disorders .2025;[Epub] CrossRef Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study Leen Heyens, Hanna Kenjic, Pieter Dagnelie, Casper Schalkwijk, Coen Stehouwer, Steven Meex, Jeroen Kooman, Otto Bekers, Marleen van Greevenbroek, Hans Savelberg, Geert Robaeys, Bastiaan de Galan, Annemarie Koster, Martien van Dongen, Simone Eussen, Ger Ko BMJ Open Gastroenterology .2024
NAMPT inhibition suppresses the senescence-associated CSC increase and resistance induced by cisplatin in ovarian tumors
What You Need to Know The specifics of people with celiac disease in the context of GLP-1 treatment involve factors that general health information does not cover
A 2011 study of elite athletes losing weight at different rates found that those losing weight slowly (around 0.7% of body weight a week) gained 2.1% lean mass over the study
Francque S, Szabo G, Abdelmalek MF, et al
Tesofensine Benefits for Bodybuilders and Active Adults While Tesofensine was initially studied in general populations with obesity, its unique pharmacology makes it increasingly relevant for athletes, physique competitors, and anyone chasing lean body recomposition
